Literature DB >> 8142127

Oral sucralfate in acute radiation oesophagitis.

R K Sur1, R Kochhar, D P Singh.   

Abstract

Eighty patients with carcinoma in the middle third of oesophagus and with acute radiation oesophagitis following external beam and intracavitary radiotherapy were managed by two different schedules. Group 1 (n = 40) received an antacid containing sodium alginate whereas Group 2 (n = 40) were given a 10% sucralfate suspension during 4 weeks. In Group 2, 32 patients had significant relief of symptoms within 7 days of treatment and most ulcers had healed by 12 days of treatment as seen on endoscopy. Patients in Group 1, on the other hand, showed little improvement of symptoms and had persistent ulcers even after 4 weeks of therapy. We conclude that sucralfate is useful in the management of acute radiation oesophagitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142127     DOI: 10.3109/02841869409098377

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  12 in total

Review 1.  Iatrogenic esophagitis.

Authors:  A S Arora; J A Murray
Journal:  Curr Gastroenterol Rep       Date:  2000-06

2.  [Oral sucralfate administration for therapy and prevention of radiation-induced esophagitis: results of a placebo-controlled double-blind study].

Authors:  C Belka
Journal:  Strahlenther Onkol       Date:  1998-06       Impact factor: 3.621

Review 3.  [Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Authors:  J S Zimmermann; P Niehoff; R Wilhelm; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

Review 4.  Overcoming toxicity-challenges in chemoradiation for non-small cell lung cancer.

Authors:  Wilma Uyterlinde
Journal:  Transl Lung Cancer Res       Date:  2016-06

Review 5.  [The use of sucralfate in radiation oncology].

Authors:  C Belka; W Hoffmann; F Paulsen; M Barnberg
Journal:  Strahlenther Onkol       Date:  1997-05       Impact factor: 3.621

6.  Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.

Authors:  Guillaume Peyraga; Delphine Caron; Thibaut Lizee; Yann Metayer; Anne-Lise Septans; Yoann Pointreau; Fabrice Denis; Gerard Ganem; Cedrik Lafond; Sophie Roche; Olivier Dupuis
Journal:  Support Care Cancer       Date:  2017-12-23       Impact factor: 3.603

Review 7.  [The therapeutic management of radiogenic oral mucositis].

Authors:  W Dörr; I Dölling-Jochem; M Baumann; T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

8.  Pharmacological and dietary prophylaxis and treatment of acute actinic esophagitis during mediastinal radiotherapy.

Authors:  F S Sasso; G Sasso; H R Marsiglia; G de Palma; C Schiavone; A Barone; A Polo; R Orecchia
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

9.  The effectiveness of sucralfate against stricture formation in experimental corrosive esophageal burns.

Authors:  Z Günyüz Temir; Aytaç Karkiner; Irfan Karaca; Ragip Ortaç; Aykut Ozdamar
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

10.  Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.

Authors:  Karl Wurstbauer; Florian Merz; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.